Iovance Biotherapeutics Inc at Jefferies Healthcare Conference (Virtual) Transcript
Good afternoon, everyone. This is Biren Amin, biotech analyst here at Jefferies. I'd like to welcome everyone to the Jefferies Healthcare Conference, I'd like to introduce our next company. We have high Iovance Biotherapeutics and their CEO, Maria Fardis; as well as CFO, Tim Morris.
This is going to be a fireside chat format. So if anyone wishes to ask management a question, you can feel free to e-mail me [email protected].
Questions & Answers
So thanks, Maria, for joining us this afternoon or morning to you, I guess. Maybe just if you could go over just top line, in terms of updates in the melanoma and cervical program, just the time lines around those product programs and when we can expect data from Cohort 4 in terms of the IRC review data as well as cervical and when we can expect data from that cohort.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |